{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:52:39Z","timestamp":1760521959177},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":723,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:sec><jats:title>Aim:<\/jats:title><jats:p>To evaluate the effectiveness of triple therapy containing either omeprazole or ranitidine bismuth citrate (RBC) to treat <jats:italic>H.\u2003pylori<\/jats:italic> infection in Vietnamese duodenal ulcer patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Patients infected with <jats:italic>H.\u2003pylori<\/jats:italic> were randomized to receive either omeprazole (20\u2003mg b.d.), clarithromycin (500\u2003mg b.d.) and amoxycillin (1\u2003g b.d.) for 10\u2003days (OAC), or RBC (400\u2003mg b.d.), clarithromycin (500\u2003mg b.d.) and amoxycillin (1\u2003g b.d.) for 10\u2003days (RAC). <jats:italic>H.\u2003pylori<\/jats:italic> eradication and ulcer healing was established by a follow\u2010up oesophagogastroduodenoscopy (EGD) at least 4\u2003weeks after therapy. Side\u2010effects and compliance were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>One hundred and four out of 108 (96%) patients with a duodenal ulcer were infected with <jats:italic>H.\u2003pylori<\/jats:italic>. Eighty per cent of infected patients had detectable CagA IgG antibodies. Fifty\u2010seven patients received OAC and 47 received RAC. OAC eradicated <jats:italic>H.\u2003pylori<\/jats:italic> in 91 and 86% of patients by per protocol (PP) and intention\u2010to\u2010treat (ITT) analysis, respectively. PP and ITT eradication rates for RAC were 96 and 91%. Ulcer healing at the follow\u2010up EGD was 89% with OAC and 100% with RAC. Side\u2010effects were minor. No patient failed to complete the protocol due to side\u2010effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Triple therapy with either omeprazole or RBC is highly effective in eradicating <jats:italic>H.\u2003pylori<\/jats:italic> and healing duodenal ulcer in Vietnamese patients.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00659.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:40:06Z","timestamp":1047354006000},"page":"97-101","source":"Crossref","is-referenced-by-count":13,"title":["Omeprazole or ranitidine bismuth citrate triple therapy to treat <i>Helicobacter pylori<\/i> infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer"],"prefix":"10.1111","volume":"14","author":[{"family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Thang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hoan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Henley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Perez\u2010Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Chey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80003-0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"e_1_2_6_4_2","first-page":"2213","article-title":"Randomized comparison of ranitidine bismuth citrate\u2010based triple therapies for Helicobacter pylori","volume":"92","author":"Laine L","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","article-title":"Helicobacter pylori in peptic ulcer disease","volume":"272","author":"NIH Consensus Conference","year":"1994","journal-title":"J Am Med Assoc"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.167_b.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.452_a.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.27.8.1870-1873.1989"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529708996529"},{"key":"e_1_2_6_10_2","first-page":"2111","article-title":"Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma","volume":"55","author":"Blaser MJ","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00230.x"},{"key":"e_1_2_6_13_2","first-page":"199","article-title":"One\u2010year follow\u2010up of duodenal ulcers after 1\u2010week triple therapy for Helicobacter pylori","volume":"89","author":"Sung JJ","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1997.tb00064.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00233.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00602.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.15.1651"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)81287-0"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)80385-5"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)80406-X"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)81079-2"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"A296","DOI":"10.1016\/S0016-5085(98)81206-7","article-title":"Prospective randomized comparison of 1\u2010week RBC\u2010triple therapy versus 1\u2010week PPI\u2010triple therapy for H.\u2003pylori\u2010related duodenal ulcers","volume":"114","author":"Sung JY","year":"1998","journal-title":"Gastroenterology"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00333.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9322501"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00659.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00659.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00659.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T06:50:22Z","timestamp":1695883822000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00659.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00659.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00659.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}